Klaus Binder
Vorstandsvorsitzender bei Binder Associates GmbH
Aktive Positionen von Klaus Binder
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Binder Associates GmbH | Vorstandsvorsitzender | - | - |
Gründer | - | - | |
Abalos Therapeutics GmbH
Abalos Therapeutics GmbH BiotechnologyHealth Technology Abalos Therapeutics GmbH engages in the development of an anti-cancer arenavirus-based drug. It focuses on awakening immune responses against tumors and metastases. The company was founded by Karl Lang and Philipp Lang and is headquartered in Essen, Germany. | Vorsitzender | 05.02.2020 | - |
Karriereverlauf von Klaus Binder
Ehemalige bekannte Positionen von Klaus Binder
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NATRIX Separations, Inc.
NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Direktor/Vorstandsmitglied | 01.12.2011 | 01.09.2017 |
Boehringer Ingelheim Pharma GmbH & Co., KG
Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach. | Corporate Officer/Principal | - | - |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | - | - |
amaxa GmbH
amaxa GmbH Miscellaneous Commercial ServicesCommercial Services amaxa GmbH researches gene transfer and gene-based medicines to develop causal therapies for the treatment of severe diseases. It focuses on high-end applications for non-viral delivery of genes and transfer of other charged substrates into cells. The company was founded in 1998 and is headquartered in Cologne, Germany. | Vorsitzender | - | - |
Statistik
International
Deutschland | 6 |
Kanada | 2 |
Operativ
Chairman | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Sektoral
Health Technology | 5 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
amaxa GmbH
amaxa GmbH Miscellaneous Commercial ServicesCommercial Services amaxa GmbH researches gene transfer and gene-based medicines to develop causal therapies for the treatment of severe diseases. It focuses on high-end applications for non-viral delivery of genes and transfer of other charged substrates into cells. The company was founded in 1998 and is headquartered in Cologne, Germany. | Commercial Services |
NATRIX Separations, Inc.
NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Health Technology |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Boehringer Ingelheim Pharma GmbH & Co., KG
Boehringer Ingelheim Pharma GmbH & Co., KG BiotechnologyHealth Technology Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach. | Health Technology |
Binder Associates GmbH | |
Abalos Therapeutics GmbH
Abalos Therapeutics GmbH BiotechnologyHealth Technology Abalos Therapeutics GmbH engages in the development of an anti-cancer arenavirus-based drug. It focuses on awakening immune responses against tumors and metastases. The company was founded by Karl Lang and Philipp Lang and is headquartered in Essen, Germany. | Health Technology |
- Börse
- Insiders
- Klaus Binder
- Erfahrung